Pivotal bioVenture Partners
Venture capitalSan Francisco · Seed–Late Stage · 7 people tracked
Also known as PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC
Investment thesis
Pivotal bioVenture Partners is a life sciences venture capital firm established in 2017, investing in transformative, therapeutic-focused healthcare companies across North America and Europe. It operates alongside affiliated strategies including Pivotal bioVenture Partners China, which focuses on venture building with healthcare companies in the Greater China region, and Pivotal Public Equity, which invests in publicly traded life sciences companies looking to scale. The broader Pivotal Life Sciences platform is a global healthcare investment firm supporting companies developing high-impact therapeutics to address major unmet medical needs.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's websiteFrequently asked questions
- What stage does Pivotal bioVenture Partners invest at?
- Pivotal bioVenture Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Pivotal bioVenture Partners focus on?
- Pivotal bioVenture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Pivotal bioVenture Partners located?
- Pivotal bioVenture Partners is headquartered in San Francisco, US.
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
Capricorn Venture Partners is a Belgium-based venture capital firm managing several funds across health, cleantech, digital, and fusion sectors, accepting pitches from companies raising capital.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
GV, originally launched as Google Ventures in 2009, is an independent venture capital firm with Alphabet as its sole limited partner. It invests from seed to growth stages across technology and life sciences and supports founders with operating partners and access to Google and Alphabet resources.